UniSa - IRIS Institutional Research Information System

Charlier, Bruno
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.072
NA - Nord America 1.415
EU - Europa 795
SA - Sud America 150
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 24
OC - Oceania 8
Totale 5.531
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 2.266
US - Stati Uniti d'America 1.365
IT - Italia 392
SG - Singapore 362
CN - Cina 149
RU - Federazione Russa 127
VN - Vietnam 111
BR - Brasile 100
DE - Germania 61
FR - Francia 50
BD - Bangladesh 49
GB - Regno Unito 41
IN - India 37
CA - Canada 23
IE - Irlanda 20
FI - Finlandia 18
AR - Argentina 17
KR - Corea 17
PL - Polonia 17
MX - Messico 15
SE - Svezia 13
ES - Italia 12
JP - Giappone 11
EC - Ecuador 10
IQ - Iraq 10
NL - Olanda 10
PK - Pakistan 9
TR - Turchia 9
AT - Austria 8
AU - Australia 8
SA - Arabia Saudita 8
UA - Ucraina 8
ZA - Sudafrica 7
BE - Belgio 5
UY - Uruguay 5
CO - Colombia 4
EG - Egitto 4
ID - Indonesia 4
KE - Kenya 4
SY - Repubblica araba siriana 4
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
PY - Paraguay 3
VE - Venezuela 3
CL - Cile 2
DZ - Algeria 2
GY - Guiana 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MM - Myanmar 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
Totale 5.465
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.257
Singapore 198
San Jose 196
Dallas 154
Ashburn 116
Chandler 93
Milan 76
Naples 53
Princeton 50
Munich 47
Ann Arbor 45
Beijing 43
Council Bluffs 39
Rome 35
Ho Chi Minh City 34
Los Angeles 34
New York 34
Lauterbourg 27
Santa Clara 23
Hanoi 22
Dublin 20
Salerno 19
Memphis 18
Dong Ket 17
The Dalles 17
Woodbridge 15
Moscow 14
Redwood City 14
São Paulo 14
Warsaw 14
Jacksonville 13
Mercato San Severino 13
Orem 13
Pune 13
Turku 13
Wokingham 13
Stockholm 12
Fisciano 11
Seattle 11
Chennai 8
Houston 8
Montreal 8
Tokyo 8
Wilmington 8
Amsterdam 7
Brooklyn 7
Buffalo 7
London 7
Phoenix 7
Arba 6
Atlanta 6
Denver 6
Montpellier 6
San Francisco 6
San Prisco 6
Adelaide 5
Boardman 5
Francavilla Fontana 5
Guangzhou 5
Haiphong 5
Izmir 5
Johannesburg 5
Montevideo 5
Nuremberg 5
Palermo 5
Seoul 5
Tianjin 5
Valencia 5
Andover 4
Aversa 4
Brasília 4
Chicago 4
Figino 4
Glasgow 4
Guayaquil 4
Mexico City 4
Nairobi 4
Norwalk 4
Ottawa 4
Quito 4
Richmond 4
Rio de Janeiro 4
Shanghai 4
The Bronx 4
Toronto 4
Verona 4
Biên Hòa 3
Bologna 3
Boston 3
Caserta 3
Fairfield 3
Hebei 3
Helsinki 3
Jakarta 3
Manchester 3
Medina 3
Mumbai 3
Nanchang 3
Nanjing 3
Napoli 3
Totale 4.140
Salva come PNG Salva come JPEG
Nome #
A UHPLC-MS/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers 799
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 584
Antioxidant Supplementation Hinders the Role of Exercise Training as a Natural Activator of SIRT1 424
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 256
Come rendere un ospedale formaldeide free 235
In Vitro Evaluation of Antibacterial and Antibiofilm Activity of Different Chlorhexidine-Containing Mouthwash Formulations against Streptococcus mutans 222
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 200
Standard addition method (SAM) in LC-MS/MS to quantify gluten-derived metabolites in urine samples 198
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 190
Chemical risk in hospital settings: Overview on monitoring strategies and international regulatory aspects 150
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease 137
Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy 136
Development and Validation of a UHPLC–MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples 130
Development and Validation of a New LC-MS/MS Bioanalytical Method for the Simultaneous Determination of Levodopa, Levodopa Methyl Ester, and Carbidopa in Human Plasma Samples 129
Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood 126
Novel Drug Targets for the Treatment of Cardiac Diseases 122
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 122
Perampanel dosage in plasma samples: development and validation of a novel HPLC method with combined UV-Fluorescence detection 122
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 119
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 119
Environmental and biological monitoring of formaldehyde inside a hospital setting: a combined approach to manage chemical risk in workplaces 117
A LC-MS/MS based methodology for the environmental monitoring of healthcare settings contaminated with antineoplastic agents 111
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications 103
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 99
Bioconversion of 4-hydroxyestradiol by extradiol ring-cleavage dioxygenases from Novosphingobium sp. PP1Y 97
Lipid nano-vesicles for thyroid hormone encapsulation: A comparison between different fabrication technologies, drug loading, and an in vitro delivery to human tendon stem/progenitor cells in 2D and 3D culture 96
Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study 95
Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry 85
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain 84
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 67
Long-Term Impact of Cenobamate on Cognition, Adaptive Behavior, and Quality of Life in Patients with Tuberous Sclerosis Complex 23
Catecholamines and Metanephrines: Quantification in the Diagnosis of Pheochromocytoma and Paraganglioma, Considerations and Critical Issues 20
Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications 11
Development, validation and real life applicability of new bioanalytical methods in the assessment and prevention of chemical risk in healthcare environments 3
Totale 5.531
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202296 0 12 0 3 6 5 3 6 5 6 12 38
2022/2023249 15 33 37 32 17 40 6 18 30 0 6 15
2023/2024191 20 17 9 13 23 38 11 12 4 8 15 21
2024/2025536 4 12 9 16 37 42 121 30 77 23 67 98
2025/20264.004 138 1.359 1.036 185 233 74 236 77 145 245 98 178
2026/2027163 153 10 0 0 0 0 0 0 0 0 0 0
Totale 5.531